# Randomized Double-blind Trial to Study the Benefit of Colchicine in Patients With Acutely Decompensated Heart Failure

Study · id `cardio:ct-nct04705987` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04705987](<https://clinicaltrials.gov/study/NCT04705987>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04705987

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 279 participants.

## Technical summary

Registry record NCT04705987. Randomized; double masking; primary purpose treatment. Start 2021-02-08 (actual); primary completion 2024-05-17 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 279 participants (enrolled count; ClinicalTrials.gov record NCT04705987, source copy `cardio:ctgov-nct04705987-2024-05-22`, retrieved 2026-10-26)
- Started: 2021-02-08 (actual) (ClinicalTrials.gov record NCT04705987, source copy `cardio:ctgov-nct04705987-2024-05-22`, retrieved 2026-10-26)
- Primary completion: 2024-05-17 (actual) (ClinicalTrials.gov record NCT04705987, source copy `cardio:ctgov-nct04705987-2024-05-22`, retrieved 2026-10-26)
- Completion: 2024-05-17 (actual) (ClinicalTrials.gov record NCT04705987, source copy `cardio:ctgov-nct04705987-2024-05-22`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT04705987, source copy `cardio:ctgov-nct04705987-2024-05-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04705987-2024-05-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Randomized Double-blind Trial to Study the Benefit of Colchicine in Patients With Acutely Decompensated Heart Failure
- Acronym: COLICA
- Condition: HEART FAILURE
- Intervention (Drug): Colchicine 0.5 MG
- Intervention (Drug): Placebo
- Lead sponsor: Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Colchicine (`cardio:colchicine`)

## Provenance

Content hash: 0904eba4a1df02e01d0bfdc3afdde59144ee8a363c19cc7662e0130b14f45390
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
